Health And Human Services Dept Orders OPVEE Nasal Spray For Emergency Fentanyl Overdose Response
Indivior PLC (NASDAQ:INDV) confirmed the first order of the OPVEE (nalmefene) nasal spray from the Biomedical Advanced Research and Development Authority (BARDA), which is the Department of Health and Human Services’ office responsible for procurement and development of medical countermeasures.
The global pharmaceutical company focused on developing medicines to treat substance use disorders (SUD) and serious mental illnesses said that OPVEE is the first and only nasal rescue medicine specifically indicated for synthetic opioids like fentanyl.
According to data from the Substance Abuse and Mental Health Services Administration, fentanyl is widespread in the illicit drug supply and more common than heroin. Overdose deaths are at historically high levels nationwide with over 108,000 people dying from overdose in 2022, as per data released by the Centers for Disease Control and Prevention (CDC). What’s more, in the one-year period ending in January …